The goal of this clinical trial is to investigate the effect of propolis administration on dysmenorrhea in endometriosis patient. the main questions it aims to answer are: * Does the propolis administration reduce symptoms of dysmenorrhea in endometriosis? * Does the propolis administration reduce the amount of oxidative stress biomarkers in endometriosis? * Does the propolis administration reduce the amount of Inflammatory biomarkers in endometriosis? Participants will be given an intervention in the form of propolis at a dose of 1 drop per 10 kilogram of body weight per administration, twice a day. there will be a control group that will be given an intervention in the form of a placebo containing 70% caramel alcohol dye solution.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Malondialdehyde (MDA)
Timeframe: week 0
Malondialdehyde (MDA)
Timeframe: week 4
Malondialdehyde (MDA)
Timeframe: week 12
Superoxide dismutase (SOD)
Timeframe: week 0
Superoxide dismutase (SOD)
Timeframe: week 4
Superoxide dismutase (SOD)
Timeframe: week 12
interleukin 6
Timeframe: week 0
interleukin 6
Timeframe: week 4
interleukin 6
Timeframe: week 12
tumor necrosis factor alpha (TNF alfa)
Timeframe: week 0
tumor necrosis factor alpha (TNF alfa)
Timeframe: week 4
tumor necrosis factor alpha (TNF alfa)
Timeframe: week 12
pain scale
Timeframe: week 0
pain scale
Timeframe: week 4
pain scale
Timeframe: week 12
Glutathione
Timeframe: week 0
Glutathione
Timeframe: week 4
Glutathione
Timeframe: week 12
8-hydroxy-2-deoxyiguanosine (8-OHdG)
Timeframe: week 0
8-hydroxy-2-deoxyiguanosine (8-OHdG)
Timeframe: week 4
8-hydroxy-2-deoxyiguanosine (8-OHdG)
Timeframe: week 12